Evidence map›Paper›PMID 41022650›Full record

ArticleExpert review of anti-infective therapy2025

Can liposomal amphotericin B be used as a preventive measure for cryptococcal meningitis?

Elizabeth L Schwartz, Nathan C Bahr, Radha Rajasingham

Abstract readEditorial
PubMed Full text at PMC Publisher
In one paragraph

Article in Expert review of anti-infective therapy, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Elizabeth L SchwartzDivision of Infectious Diseases and International Medicine, Department of Medicine, University of Minnesota, Minneapolis, MN, USA.ORCID 0000-0002-9550-0635
Nathan C BahrDivision of Infectious Diseases and International Medicine, Department of Medicine, University of Minnesota, Minneapolis, MN, USA.ORCID 0000-0002-9431-8938
Radha RajasinghamDivision of Infectious Diseases and International Medicine, Department of Medicine, University of Minnesota, Minneapolis, MN, USA.

Funding

Medical Scientist Training ProgramT32GM156735 · NIGMS · UNIVERSITY OF MINNESOTA · PI YOJI SHIMIZU · 2025 to 2026
$2.6M
Enhanced Antifungal Therapy to Improve Survival in Early Disseminated Cryptococcal InfectionU01AI174978 · NIAID · UNIVERSITY OF MINNESOTA · PI Radha Rajasingham · 2023 to 2026
$2.6M
Novel Diagnostic Development for TB Meningitis and HistoplasmosisK23NS110470 · NINDS · UNIVERSITY OF MINNESOTA · PI BAHR, NATHAN · 2019 to 2023
$1.0M
NIAID NIH HHS U01 AI174978NIGMS NIH HHS T32 GM156735NINDS NIH HHS K23 NS110470
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Cryptococcal antigenemiacryptococcal meningitiscryptococcosisliposomal amphotericin Bprevention

Identifiers

PMID41022650
PMCPMC12648203

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.